Area of research
Immunology · Oncology
Research interest
Research interests include Immune Cell Function and Interaction, Cancer Immunotherapy and Biomarkers, Immune cells in cancer, and Cancer, Stress, Anesthesia, and Immune Response.
The time-to-surgery interval and its effect on pathological response after neoadjuvant chemoimmunotherapy in non-small cell lung cancer: a retrospective cohort study
Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration
Suppression of local type I interferon by gut microbiota–derived butyrate impairs antitumor effects of ionizing radiation
Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunity
All-trans retinoic acid overcomes solid tumor radioresistance by inducing inflammatory macrophages
Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling
RIG-I–Like Receptor LGP2 Is Required for Tumor Control by Radiotherapy
Computational systematic selectivity of the Fasalog inhibitors between ROCK-I and ROCK-II kinase isoforms in Alzheimer’s disease
Tumor-reprogrammed resident T cells resist radiation to control tumors
Non-canonical NF-κB Antagonizes STING Sensor-Mediated DNA Sensing in Radiotherapy
Host STING-dependent MDSC mobilization drives extrinsic radiation resistance
Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-AKR1C1 pathway